Butterfly, A $1.25 Billion Healthtech Company, Launches New Ultrasound Technology In The U.K.

Wednesday September 25 saw the U.K. launch of a device that has the potential to change the way ultrasound scans are performed. In a nutshell, Butterfly Network‘s technology turns a smartphone into an ultrasound machine, but the catchy tagline is arguably reductive for a company with its sights set on democratizing healthcare for the 4.7 billion people around the world lacking access to medical imaging. Already, the company has raised $250 million investment at a $1.25 billion valuation from the likes of The Bill and Melinda Gates Foundation, Fidelity and Fosun Pharma, demonstrating their global intent.

Healthy.io Raises $60 Million Series C And Receives FDA Clearance For Smartphone-Based Diagnostic Test

Today, Healthy.io, an Israel-based healthtech startup that turns smartphone cameras into urine-testing medical devices, has announced a $60 million Series C funding round. The company has also received FDA clearance from the U.S. Food and Drug Administration (FDA) for its smartphone-based test to be used in the aid of diagnosing chronic kidney disease (CKD), which affects over 35 million Americans.

Read the full article in Forbes.

Could The NHS Really Sell Its Data For $12 Billion?

A new report by consulting firm EY suggests that if the U.K. National Health Service (NHS) datasets were put to use, their value could be up to £9.6 billion ($12 billion) per year. This data is held within 55 million patient records and according to the report, a typical electronic health record is worth about £100 ($125), while one that’s linked to detailed genomic data can fetch as much as £5,000 ($6,200). That means an overall value of £5 billion ($6.2 billion) to commercial partners and £4.6 billion ($5.7 billion) per year in health economic benefits to patients.

Read the full article on Forbes.